References
- Leal PC, Clivatti J, Garcia JBS, Sakata RK. Opioid-induced hyperalgesia. Braz J Anesthesiol. 2010;60(6):643–7.
- Low Y, Clarke CF, Huh BK. Opioid-induced hyperalgesia: a review of epidemiology, mechanisms and management. Singapore Med J. 2012;53(5):357–60.
- Tompkins DA, Campbell CM. Opioid-induced hyperalgesia: clinically relevant or extraneous research phenomenon? Curr Pain Headache Rep 2011;15(2):129–36.
- Fallon M, Colvin L. Opioid-induced hyperalgesia: fact or fiction? Palliat Med 2008;22(1):5–6.
- Zylicz Z, Twycross R. Opioid-induced hyperalgesia may be more frequent than previously thought. JCO 2008;26(9):1564.
- Jensen KB, Lonsdorf TB, Schalling M, Kosek E, Ingvar M. Increased sensitivity to thermal pain following a single opiate dose is influenced by the COMT val158met Polymorphism. PLoS ONE 2009;4(6):e6016.
- Liang DY, Liao G, Lighthall GK, Peltz G, Clark DJ. Genetic variants of the P-glycoprotein gene Abcb1b modulate opioid-induced hyperalgesia, tolerance and dependence. Pharmacogenet Genom. 2006;16(11):825–35.
- Donaldson R, Sun Y, Liang D-Y, et al. The multiple PDZ domain protein Mpdz/MUPP1 regulates opioid tolerance and opioid-induced hyperalgesia. BMC Genomics 2016;17:313.
- Oladosu FA, Conrad MC, O’Buckley SC, Rashid NU, Slade DG, Nackley AG. Mu opioid splice variant MOR-1K contributes to the development of opioid-induced hyperalgesia. PLoS One 2015;10(8):e0135711.